Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
58.73
-0.99 (-1.66%)
At close: Apr 28, 2026, 4:00 PM EDT
58.17
-0.56 (-0.95%)
After-hours: Apr 28, 2026, 5:29 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.45 billion as of April 28, 2026. Its market cap has increased by 134.11% in one year.
Market Cap
8.45B
Enterprise Value
7.01B
1-Year Change
134.11%
Ranking
Category
Stock Price
$58.73
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.45B, an increase of 512.51%. That is a compound annual growth rate of 36.18%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.40B |
| Arrowhead Pharmaceuticals | 10.31B |
| Axsome Therapeutics | 9.59B |
| Praxis Precision Medicines | 9.22B |
| ABIVAX Société Anonyme | 8.98B |
| Bio-Techne | 8.62B |
| Nuvalent | 8.18B |
| Krystal Biotech | 8.03B |